Momenta Pharmaceuticals (MNTA)
Add to Watchlists Create an Alert
13.32
+0.06 +0.41%
NASDAQ
May 23, 4:59PM
BATS Real time
Currency in USD
Momenta Pharmaceuticals Retained Earnings Quarterly YoY Growth
Momenta Pharmaceuticals Historical Retained Earnings Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
About Retained Earnings Growth
Retained Earnings Growth is the percent increase/decrease of a company's retained net income over time. A company can use retained earnings to maintain current operations, or to invest in new ventures. Generally speaking, retained earnings growth is accompanied by subsequent increases in sales and profitability.
If a company's retained earnings at the end of 2008 were $12 million, and by the end of 2009 the company's retained earnings increased to $15 million, the company experienced a retained earnings growth of 25%.
Learn More
MNTA Retained Earnings Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Teva Pharmaceutical Industries | 6.70% |
| Mylan | 39.92% |
| Ligand Pharmaceuticals |
MNTA News
Momenta Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha Apr 30
Seeking Alpha Apr 30